Read the full judgment text of HCA 2733/2015 on BabelCite. This High Court CFI judgment was delivered on 20 January 2021.
1. The 1 st Plaintiff (“ P1 ”) [1] was a Hong Kong company. It carried on business in research and development of bio-medical diagnostic products and provided molecular diagnostic laboratory services in Hong Kong. It had a plan (the “ Plan ”) to extend its service and products to the Mainland. The plan involved the formation of a wholly owned foreign enterprise (“ WOFE ”) to hold an independent diagnostic/clinical laboratory (“ ICL ”) in the Mainland. Whether that was possible would be depen
Cited by 2 cases